secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001522767-24-000040
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q1 2024 revenue up 10% to $37.9M; net loss widens to $1.3M, adjusted EBITDA down
--------------------------------------------------------------------------------

- Revenue of $37.9M (+10% YoY); GAAP gross margin 43% vs 45% in prior year.
- GAAP net loss $1.3M (vs $0.7M loss); non-GAAP net loss $0.6M (vs $0.3M income).
- Adjusted EBITDA $4.7M vs $7.1M; margin 12% vs 21%; CEO cites wholesale growth.
- 17th consecutive quarter of positive adjusted EBITDA; management reaffirms strategic plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276724000040/0001522767-24-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276724000040/mrmd-20240508.htm
  HTML page:      https://secwatch.observer/filing/0001522767-24-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer